Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX) earnings
QNRX earnings moved a median of -0.63% by the close. Quarterly and annual QNRX reports and results, each read against the price at its own news timestamp. Back to the QNRX overview →
30 measured QNRX earnings events.
Where these QNRX earnings landedvs 30 measured QNRX earnings reactions
| Middle 50% of QNRX earnings reactions | -6.91% to +2.06% |
|---|---|
| Median reaction (to close) | -0.63% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 QNRX earnings events with a measured close landed between -6.91% and +2.06%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Quoin Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +9.03% | |
| Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results | Press release | -5.60% | +1.80% | |
| Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026 | Press release | +0.00% | +0.00% | |
| Form 10-Q Quoin Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.45% | +1.59% | |
| Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results | Press release | -6.35% | -4.78% | |
| Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026 | Press release | -0.67% | +8.54% | |
| Form 10-K Quoin Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.05% | -13.49% | |
| Form 10-Q Quoin Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | +5.88% | |
| Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results | Press release | +3.44% | -11.19% | |
| Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | Press release | +3.69% | -8.35% | |
| Form 10-Q Quoin Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.14% | +2.14% | |
| Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update | Press release | — | -4.69% | |
| Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025 | Press release | -2.03% | -9.46% | |
| Form 10-Q Quoin Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -12.57% | |
| Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results | Press release | -4.22% | -0.63% | |
| Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025 | Press release | -3.21% | -2.05% | |
| Form 10-K Quoin Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +2.10% | +4.09% | |
| Form 10-Q Quoin Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.71% | -4.29% | |
| Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results | Press release | +3.47% | -6.38% | |
| Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024 | Press release | +0.93% | +2.49% | |
| Form 10-Q Quoin Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +8.16% | +1.14% | |
| Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results | Press release | -0.02% | -7.17% | |
| Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | -3.39% | -0.09% | |
| Form 10-Q Quoin Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.45% | +0.21% | |
| Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results | Press release | -2.19% | -0.63% | |
| Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024 | Press release | +1.64% | +6.34% | |
| Form 10-K Quoin Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.94% | -7.09% | |
| Form 10-Q Quoin Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.28% | |
| Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results | Press release | — | -7.74% | |
| Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET | Press release | +0.72% | +6.46% |
Keep exploring
More QNRX: analyst actions → · SEC filings → · QNRX overview →